Physician profile
Gursant Atwal
NPI 1992041461
$5,414.49
in general payments reported to CMS, 2019-2025
8 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,951 · 2020: $109 · 2022: $233 · 2023: $416 · 2024: $229 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $3,918.39 | 2019 | |
| Zimmer Biomet Holdings, INC. | $517.87 | 2023-2025 | Neuro Plating System, Neuro Plating System |
| Aesculap, INC. | $393.78 | 2022-2025 | Aesculap |
| Lemaitre Vascular, INC. | $217.88 | 2023-2025 | Restoreflow, Anastoclip Gc 8cm (Medium), Cardiocel |
| Medical Device Business Services, INC. | $141.33 | 2022 | |
| Microvention, INC. | $141.22 | 2020-2024 | Sofia 6f-131cm Str, Eric Retrieval Device, Web Aneurysm Embolization System |
| Stryker Corporation | $59.16 | 2019-2023 | Core |
| Abbott Laboratories | $24.86 | 2023 | Perclose Proglide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gursant Atwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.